[ad_1] Pharmaceutical companies could try to blunt the limits on future price increases. [ad_2] Source link
Tag: Amgen
As the U.S. Gets Older, Some ETFs Bet on Aging in Place
[ad_1] A number of thematic funds are focused on companies that help seniors who want to stay in their homes as long as possible. [ad_2] Source link
Investors’ Best Friend in 2022: The Dogs of the Dow
[ad_1] The 10 stocks with the highest dividend yields of the Dow components at the beginning of last year rose 2.2%. [ad_2] Source link
Drugmakers Spent Freely in 2022 to Protect Revenue
[ad_1] Pfizer, Amgen and Bristol-Myers Squibb bought makers of proven drugs ahead of potential rising competition from generics. [ad_2] Source link
Amgen Hunts for New Revenue in $28 Billion Deal
[ad_1] Health The purchase of Horizon brings in rare-disease drugs with billions of dollars in sales that could offset revenue drops from patent expiries [ad_2] Source link
First Test for Amgen: Fix Horizon’s Growth Problem
[ad_1] Markets Heard on the Street Sales of Horizon’s thyroid-eye disease drug Tepezza have plateaued, a challenge its new owner will need to contend with [ad_2] Source link
WSJ News Exclusive | Amgen in Advanced Talks to Buy Horizon Therapeutics
[ad_1] WSJ News Exclusive Business U.S. biotechnology company was the last of three suitors standing in an auction for Horizon [ad_2] Source link